Noninvasive diagnosis of acute rejection of renal allografts

Choli Hartono, Thangamani Muthukumar, Manikkam Suthanthiran

Research output: Contribution to journalReview article

59 Citations (Scopus)

Abstract

Purpose of review: Acute rejection is an immune process that begins with the recognition of the allograft as nonself and ends in graft destruction. Histological features of the allograft biopsy are currently used for the differential diagnosis of allograft dysfunction. In view of the safety and the opportunity for repetitive sampling, development of noninvasive biomarkers of allograft status is an important objective in transplantation. Herein, we review some of the progress towards the development of noninvasive biomarkers of human allograft status. Recent findings: Urinary cell and peripheral blood cell mRNA profiles have been associated with acute rejection of human renal allografts. Emerging data support the idea that development of noninvasive biomarkers predictive of antibody-mediated rejection is feasible. The demonstration that intragraft microRNA expression predicts renal allograft status suggests that noninvasively ascertained microRNA profiles may be of value. Summary: We are pleased with the progress to date, and anticipate clinical trials investigating the hypotheses that noninvasively ascertained mRNA profiles will minimize the need for invasive biopsy procedures, predict the development of acute rejection and chronic allograft nephropathy, facilitate preemptive therapy capable of preserving graft function, and facilitate personalization of immunosuppressive therapy for the allograft recipient.

Original languageEnglish
Pages (from-to)35-41
Number of pages7
JournalCurrent Opinion in Organ Transplantation
Volume15
Issue number1
DOIs
Publication statusPublished - 1 Feb 2010
Externally publishedYes

Fingerprint

Allografts
Kidney
Biomarkers
MicroRNAs
Transplants
Biopsy
Messenger RNA
Immunosuppressive Agents
Blood Cells
Differential Diagnosis
Transplantation
Clinical Trials
Safety
Antibodies
Therapeutics

Keywords

  • Acute rejection
  • mRNA profiling
  • Transplantation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation

Cite this

Noninvasive diagnosis of acute rejection of renal allografts. / Hartono, Choli; Muthukumar, Thangamani; Suthanthiran, Manikkam.

In: Current Opinion in Organ Transplantation, Vol. 15, No. 1, 01.02.2010, p. 35-41.

Research output: Contribution to journalReview article

Hartono, Choli ; Muthukumar, Thangamani ; Suthanthiran, Manikkam. / Noninvasive diagnosis of acute rejection of renal allografts. In: Current Opinion in Organ Transplantation. 2010 ; Vol. 15, No. 1. pp. 35-41.
@article{978de4854d62474985129a13a5f2f447,
title = "Noninvasive diagnosis of acute rejection of renal allografts",
abstract = "Purpose of review: Acute rejection is an immune process that begins with the recognition of the allograft as nonself and ends in graft destruction. Histological features of the allograft biopsy are currently used for the differential diagnosis of allograft dysfunction. In view of the safety and the opportunity for repetitive sampling, development of noninvasive biomarkers of allograft status is an important objective in transplantation. Herein, we review some of the progress towards the development of noninvasive biomarkers of human allograft status. Recent findings: Urinary cell and peripheral blood cell mRNA profiles have been associated with acute rejection of human renal allografts. Emerging data support the idea that development of noninvasive biomarkers predictive of antibody-mediated rejection is feasible. The demonstration that intragraft microRNA expression predicts renal allograft status suggests that noninvasively ascertained microRNA profiles may be of value. Summary: We are pleased with the progress to date, and anticipate clinical trials investigating the hypotheses that noninvasively ascertained mRNA profiles will minimize the need for invasive biopsy procedures, predict the development of acute rejection and chronic allograft nephropathy, facilitate preemptive therapy capable of preserving graft function, and facilitate personalization of immunosuppressive therapy for the allograft recipient.",
keywords = "Acute rejection, mRNA profiling, Transplantation",
author = "Choli Hartono and Thangamani Muthukumar and Manikkam Suthanthiran",
year = "2010",
month = "2",
day = "1",
doi = "10.1097/MOT.0b013e3283342728",
language = "English",
volume = "15",
pages = "35--41",
journal = "Current Opinion in Organ Transplantation",
issn = "1087-2418",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Noninvasive diagnosis of acute rejection of renal allografts

AU - Hartono, Choli

AU - Muthukumar, Thangamani

AU - Suthanthiran, Manikkam

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Purpose of review: Acute rejection is an immune process that begins with the recognition of the allograft as nonself and ends in graft destruction. Histological features of the allograft biopsy are currently used for the differential diagnosis of allograft dysfunction. In view of the safety and the opportunity for repetitive sampling, development of noninvasive biomarkers of allograft status is an important objective in transplantation. Herein, we review some of the progress towards the development of noninvasive biomarkers of human allograft status. Recent findings: Urinary cell and peripheral blood cell mRNA profiles have been associated with acute rejection of human renal allografts. Emerging data support the idea that development of noninvasive biomarkers predictive of antibody-mediated rejection is feasible. The demonstration that intragraft microRNA expression predicts renal allograft status suggests that noninvasively ascertained microRNA profiles may be of value. Summary: We are pleased with the progress to date, and anticipate clinical trials investigating the hypotheses that noninvasively ascertained mRNA profiles will minimize the need for invasive biopsy procedures, predict the development of acute rejection and chronic allograft nephropathy, facilitate preemptive therapy capable of preserving graft function, and facilitate personalization of immunosuppressive therapy for the allograft recipient.

AB - Purpose of review: Acute rejection is an immune process that begins with the recognition of the allograft as nonself and ends in graft destruction. Histological features of the allograft biopsy are currently used for the differential diagnosis of allograft dysfunction. In view of the safety and the opportunity for repetitive sampling, development of noninvasive biomarkers of allograft status is an important objective in transplantation. Herein, we review some of the progress towards the development of noninvasive biomarkers of human allograft status. Recent findings: Urinary cell and peripheral blood cell mRNA profiles have been associated with acute rejection of human renal allografts. Emerging data support the idea that development of noninvasive biomarkers predictive of antibody-mediated rejection is feasible. The demonstration that intragraft microRNA expression predicts renal allograft status suggests that noninvasively ascertained microRNA profiles may be of value. Summary: We are pleased with the progress to date, and anticipate clinical trials investigating the hypotheses that noninvasively ascertained mRNA profiles will minimize the need for invasive biopsy procedures, predict the development of acute rejection and chronic allograft nephropathy, facilitate preemptive therapy capable of preserving graft function, and facilitate personalization of immunosuppressive therapy for the allograft recipient.

KW - Acute rejection

KW - mRNA profiling

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=75749144327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75749144327&partnerID=8YFLogxK

U2 - 10.1097/MOT.0b013e3283342728

DO - 10.1097/MOT.0b013e3283342728

M3 - Review article

VL - 15

SP - 35

EP - 41

JO - Current Opinion in Organ Transplantation

JF - Current Opinion in Organ Transplantation

SN - 1087-2418

IS - 1

ER -